Related references
Note: Only part of the references are listed.Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Predicting Radiotherapy Responses and Treatment outcomes Through Analysis of Circulating Tumor DNA
Aadel A. Chaudhuri et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
SINE transcription by RNA polymerase III is suppressed by histone methylation but not by DNA methylation
Dhaval Varshney et al.
NATURE COMMUNICATIONS (2015)
Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
Mantang Qiu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Prostate cancer epigenetic biomarkers: next-generation technologies
F. Valdes-Mora et al.
ONCOGENE (2015)
DNA damage response and prostate cancer: defects, regulation and therapeutic implications
S. Karanika et al.
ONCOGENE (2015)
The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium
Fabio A. B. Schutz et al.
EUROPEAN UROLOGY (2014)
Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen
Jiang Feng et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
Going with the Flow: From Circulating Tumor Cells to DNA
Francois-Clement Bidard et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Characterization of cell-free circulating DNA in plasma in patients with prostate cancer
Pamela Oliveira Delgado et al.
TUMOR BIOLOGY (2013)
Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients
Marcelo L. Wroclawski et al.
TUMOR BIOLOGY (2013)
Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
Valentina Casadio et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Vascular endothelin receptor type B: Structure, function and dysregulation in vascular disease
Marc Q. Mazzuca et al.
BIOCHEMICAL PHARMACOLOGY (2012)
DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate Cancer
Lissette Delgado-Cruzata et al.
DNA AND CELL BIOLOGY (2012)
Epigenetic markers of prostate cancer in plasma circulating DNA
Rene Cortese et al.
HUMAN MOLECULAR GENETICS (2012)
Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
Joerg Ellinger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
T. Wu et al.
BRITISH JOURNAL OF CANCER (2011)
Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients
Heidi Schwarzenbach et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaive castration-resistant prostate cancer
Guru Sonpavde et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
American Cancer Society Guideline for the Early Detection of Prostate Cancer Update 2010
Andrew M. D. Wolf et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease
Edna Gordian et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
Ugur Deligezer et al.
CLINICA CHIMICA ACTA (2010)
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2009)
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
Eiji Sunami et al.
CLINICAL CHEMISTRY (2009)
DNA Methylation Biomarkers of Prostate Cancer: Confirmation of Candidates and Evidence Urine is the Most Sensitive Body Fluid for Non-Invasive Detection
Shannon R. Payne et al.
PROSTATE (2009)
A systematic review of the diagnostic accuracy of prostate specific antigen
Philip Harvey et al.
BMC Urology (2009)
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer
Annalisa Altimari et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors
Anna V. Cherepanova et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients
Olga E. Bryzgunova et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Mitochondrial DNA in serum of patients with prostate cancer:: a predictor of biochemical recurrence after prostatectomy
Joerg Ellinger et al.
BJU INTERNATIONAL (2008)
Performance of a Single Assay for Both Type III and Type VI TMPRSS2:ERG Fusions in Noninvasive Prediction of Prostate Biopsy Outcome
Jarrod P. Clark et al.
CLINICAL CHEMISTRY (2008)
Development of a multiplexed urine assay for prostate cancer diagnosis
Tatiana Vener et al.
CLINICAL CHEMISTRY (2008)
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
Joerg Ellinger et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer
Patrick J. Bastian et al.
JOURNAL OF UROLOGY (2008)
CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer
Joerg Ellinger et al.
PROSTATE (2008)
Adenomatous polyposis coli (APC):: a multi-functional tumor suppressor gene
Koji Aoki et al.
JOURNAL OF CELL SCIENCE (2007)
Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectorny
Patrick J. Bastian et al.
CLINICAL CANCER RESEARCH (2007)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
Patrick J. Bastian et al.
EUROPEAN UROLOGY (2007)
Is the quantity of circulatory cell-free DNA in human plasma and serum samples associated with gender, age and frequency of blood donations?
Xiao Yan Zhong et al.
ANNALS OF HEMATOLOGY (2007)
Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer
Niven Mehra et al.
CLINICAL CANCER RESEARCH (2007)
Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor
Susana Alvarez et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer
Heidi Schwarzenbach et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Circulating nucleic acids (CNAs) and cancer - A survey
M. Fleischhacker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection
Craig G. Rogers et al.
JOURNAL OF UROLOGY (2006)
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer
Felix K. -H. Chun et al.
BJU INTERNATIONAL (2006)
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects
MO Hoque et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy
PJ Bastian et al.
CLINICAL CANCER RESEARCH (2005)
Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease
JL Boddy et al.
CLINICAL CANCER RESEARCH (2005)
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer
K Jung et al.
CANCER LETTERS (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Allelic losses in localized prostate cancer: Association with prognostic factors
G Fromont et al.
JOURNAL OF UROLOGY (2003)
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neuregulin promotes autophagic cell death of prostate cancer cells
P Tal-Or et al.
PROSTATE (2003)
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
M Esteller
ONCOGENE (2002)
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
TL Wu et al.
CLINICA CHIMICA ACTA (2002)
SINEs and LINEs: the art of biting the hand that feeds you
AM Weiner
CURRENT OPINION IN CELL BIOLOGY (2002)
DNA repair mediated by endonuclease-independent LINE-1 retrotransposition
TA Morrish et al.
NATURE GENETICS (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Feasibility of assessment of promoter methylation of the CD44 gene in serum of prostate cancer patients
AN Vis et al.
MOLECULAR UROLOGY (2001)
Share Paper
